ArticleHaematologica2016

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma.

Esther Drent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.